1) The document discusses using protein structures as targets for ligand design in drug development. It provides examples of targeting matrix metalloproteinase 9 (MMP9), cellulases, and a serine protease from fire ants. 2) Specific protein structures that are discussed include truncated forms of MMP9, cellulases from Aspergillus niger and a wood-eating termite, and a C3 serine protease from fire ants. Crystallization and characterization methods are described. 3) The structures provide insight into binding sites and catalytic domains that can be targeted by small molecule ligands during structure-based drug design to develop inhibitors for conditions like cancer metastasis and termite damage.